secwatch.observer — SEC 8-K summary
======================================

Issuer:     TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
CIK:        0001027838
Form:       8-K
Filed at:   2024-11-04T23:59:59+00:00
Accession:  0001558370-24-014254
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tactile Medical Q3 revenue up 5% to $73.1M; guides FY2024 $292-295M, authorizes $30M buyback
--------------------------------------------------------------------------------

- Q3 revenue $73.1M (+5% YoY); lymphedema +4%, airway clearance +10%.
- Net income $5.2M ($0.21 diluted) vs $22.3M in Q3 2023; adjusted EBITDA $10.7M vs $7.7M.
- Gross margin improved to 75.0% from 70.9%; operating expenses up 16%.
- FY2024 revenue guidance narrowed to $292-295M (prior $293-298M; growth 6-8%).
- Board authorized up to $30M share repurchase program through Oct 31, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1027838/000155837024014254/0001558370-24-014254-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1027838/000155837024014254/tcmd-20241104x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-014254

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer